These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21150234)

  • 1. Hemoptysis under diclofenac and antiplatelet doses of aspirin.
    Yiannakopoulou EC
    Pharmacology; 2011; 87(1-2):1-4. PubMed ID: 21150234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
    Hohlfeld T; Saxena A; Schrör K
    Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation.
    Galliard-Grigioni KS; Reinhart WH
    Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemoptysis during lung biopsy after aspirin.
    vanSonnenberg E; Wittich G
    AJR Am J Roentgenol; 1998 Jul; 171(1):261. PubMed ID: 9648801
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose aspirin for everyone?
    Johns Hopkins Med Lett Health After 50; 2002 Oct; 14(8):4-5. PubMed ID: 12425276
    [No Abstract]   [Full Text] [Related]  

  • 8. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinitiating aspirin therapy for primary prevention of cardiovascular events in a patient post-aspirin-induced upper gastrointestinal bleed: a case report and review of literature.
    Adly G; Plakogiannis R
    Ann Pharmacother; 2013 Feb; 47(2):e8. PubMed ID: 23386069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation.
    Galliard-Grigioni KS; Fehr M; Reinhart WH
    Eur J Pharmacol; 2008 Oct; 595(1-3):65-8. PubMed ID: 18700139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemoptysis and pulmonary edema in a scuba diver using diclofenac.
    Van Renterghem D; Depuydt C
    Pharmacology; 2012; 89(1-2):103-4. PubMed ID: 22354373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antiplatelet activity of COX1 NSAIDS versus aspirin, encompassing regimen simplification and gastroprotection: a call for a controlled study.
    Rothschild BM
    Reumatismo; 2004; 56(2):89-93. PubMed ID: 15309216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical diclofenac does not affect the antiplatelet properties of aspirin as compared to the intermediate effects of oral diclofenac: A prospective, randomized, complete crossover study.
    Rowcliffe M; Nezami B; Westphal ES; Rainka M; Janda M; Bates V; Gengo F
    J Clin Pharmacol; 2016 Apr; 56(4):422-8. PubMed ID: 26265197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
    Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P; Jezovnik MK
    Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers.
    Gladding PA; Webster MW; Farrell HB; Zeng IS; Park R; Ruijne N
    Am J Cardiol; 2008 Apr; 101(7):1060-3. PubMed ID: 18359332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.